NCT02166944View on ClinicalTrials.gov

Tamoxifen Treatment in Patients With Motor Neuron Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 17, 2019

Study Completion Date

September 18, 2019

Conditions
Amyotrophic Lateral SclerosisALS Functional Ration ScaleTAR-DNA-binding Protein-43TamoxifenmTOR
Interventions
DRUG

tamoxifen 40 mg daily for one year

both arms with riluzole daily

Trial Locations (1)

Unknown

Po-Chih Chen, New Taipei City

All Listed Sponsors
lead

Taipei Medical University Shuang Ho Hospital

OTHER

NCT02166944 - Tamoxifen Treatment in Patients With Motor Neuron Disease | Biotech Hunter | Biotech Hunter